Research Foundation For Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 0.54 M
as on 20-12-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Revenue %
(FY 2016)
- Profit 34.82%
(FY 2016)
- Ebitda 34.82%
(FY 2016)
- Net Worth -1.81%
(FY 2016)
- Total Assets %
(FY 2016)
About Research Foundation For Medical Sciences
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.54 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrabhaga Deshmukh, Mahadev Deshmukh, Bapu Sakhare, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73100PN2000PLC014515
- Company No.
014515
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2000
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- LocationSatara, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Research Foundation For Medical Sciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrabhaga Deshmukh  | Director | 23-Feb-2000 | Current |
| Mahadev Deshmukh | Director | 23-Feb-2000 | Current |
| Bapu Sakhare | Additional Director | 20-Aug-2021 | Current |
| Lahu Mandave | Additional Director | 20-Aug-2021 | Current |
| Rahul Deb | Additional Director | 19-Jul-2021 | Current |
| Dattatraya Khade | Director | 23-Feb-2000 | Current |
Financial Performance of Research Foundation For Medical Sciences.
Research Foundation For Medical Sciences Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 34.82% increase in profit. The company's net worth dipped by a decrease of 1.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Research Foundation For Medical Sciences?
In 2016, Research Foundation For Medical Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Research Foundation For Medical Sciences?
Unlock and access historical data on people associated with Research Foundation For Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Research Foundation For Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Research Foundation For Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
